Skip to main content

Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference

PR Newswire - Thu Oct 19, 2023

EMERYVILLE, Calif., Oct. 19, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference on Wednesday, October 25 at 1:00 p.m. ET.

Read more at prnewswire.com
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.